Fc galactosylation follows consecutive reaction kinetics and enhances immunoglobulin G hexamerization for complement activation
Fc galactosylation is a critical quality attribute for anti-tumor recombinant immunoglobulin G (IgG)-based monoclonal antibody (mAb) therapeutics with complement-dependent cytotoxicity (CDC) as the mechanism of action. Although the correlation between galactosylation and CDC has been known, the unde...
Váldodahkkit: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Materiálatiipa: | Artihkal |
Giella: | English |
Almmustuhtton: |
Taylor & Francis Group
2021-01-01
|
Ráidu: | mAbs |
Fáttát: | |
Liŋkkat: | https://www.tandfonline.com/doi/10.1080/19420862.2021.1893427 |